ThursdayJan 25, 2018 12:35 pm

Liberty Leaf Holdings Ltd. (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) Closes $2 Million in Private Placement Financing

Company’s subsidiaries set sights on recreational use licensing, expansion Total marijuana market in Canada forecast to hit $2.8 billion by 2020 Pet cannabis products for pain expected to form large market opportunity Liberty Leaf Holdings Ltd. (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) announced on January 22 that it had closed a private placement financing effort with $2 million in gross proceeds that will be used to speed completion of facility construction projects for its subsidiaries, North Road Ventures in the greater Vancouver area of Canada’s British Columbia and Just Kush Enterprises, located some 250 miles to the east. Just Kush…

Continue Reading

WednesdayJan 24, 2018 3:51 pm

Proposed Transdermal Treatment for Veterans with PTSD a Top Priority of Skinvisible, Inc. (SKVI) and Quoin Pharmaceuticals

Proposed transdermal product will help veterans struggling with PTSD and suicidal thoughts Majority of suicides among military veterans are among those 50 and older Suicide rate for U.S. women veterans was 2.5 times higher than civilian adult women Presidential executive order signed January 9, 2018, focuses on providing mental health care to former service members Topical and transdermal product development company Skinvisible, Inc. (OTCQB: SKVI) and its patented Invisicare® technology could provide significant relief to veterans with post-traumatic stress disorder through a proposed transdermal treatment the company expects to develop as it merges with Quoin Pharmaceuticals Ltd. The proposed merger,…

Continue Reading

WednesdayJan 24, 2018 1:56 pm

ChineseInvestors.com, Inc. (CIIX) Plans To Expand and Make a Lasting Impact in the Coming Year

CIIX has created a Yelp-style app for marijuana dispensaries and cannabis strains to help it achieve big goals in 2018 CIIX is committed to forward movement toward a cure for epilepsy Company is expanding its market reach in the U.S., Canada and China through hemp-based products ChineseInvestors.com, Inc.’s (OTCQB: CIIX) mission is to become the leading publicly traded company targeting Chinese medicinal marijuana. Offering a variety of investor education products and services, Warren Wang, CEO and founder, would like to see 2018 bring with it double the revenue and expanded business. One of the ways CIIX is tackling this goal is…

Continue Reading

TuesdayJan 23, 2018 3:47 pm

Grey Cloak Tech’s (GRCK) Recent Eqova Acquisition Positions the Company for Growth on Booming CBD Market

Hemp-derived cannabidiol (CBD) sales projected to surpass $1 billion in five years Grey Cloak Tech has acquired Eqova Life Sciences, an established producer of a range of clinical-grade CBD products This acquisition strengthens Grey Cloak’s position in this market sector and is likely to accelerate its growth On the back of several forecasts of explosive growth in the cannabidiol (CBD) market, Grey Cloak Tech, Inc. (OTCQB: GRCK) has made a strategic decision to focus its efforts in this sector. The Hemp Business Journal reports projected growth of 700 percent by 2020, to reach annual sales of $2.1 billion, according to…

Continue Reading

TuesdayJan 23, 2018 1:07 pm

Disrupting Drug Delivery Platform Keeps Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Portfolio Growing

Patented technology promotes healthier administration of active pharmaceutical ingredients, including cannabidiol (CBD), psychoactive cannabinoids (THC), nicotine, fat soluble vitamins and nonsteroidal anti-inflammatory drugs Active pharmaceutical ingredient market expected to exceed $239 billion by 2025 19 patent applications filed in U.S. and internationally encompassing 44 countries Lab tests in 2018 include topical CBD skin cream, nicotine in edible formats Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses a patented drug delivery platform called DehydraTECH™ that changes the way active pharmaceutical ingredients (“APIs”) enter the body orally. According to a new report by Million…

Continue Reading

MondayJan 22, 2018 3:17 pm

Skinvisible, Inc. (SKVI) Set to Repeat Olympic Performance in 2018 with DermSafe

Targeting $80 billion global skincare and dermatology market Revenues to be derived from royalties and other licensing fees DermSafe sales have taken off in Greater China Pending merger will expand product offerings Among the winners at the 2016 Summer Olympics in Rio was DermSafe® from Skinvisible’s (OTCQB: SKVI) subsidiary, Kintari. Donated to Team Canada, the non-alcohol hand sanitizing lotion offered protection from pathogens to athletes during the Olympic Games. Now, with the Winter Olympics to be held in South Korea from February 8-25, the need is more pressing. Reported outbreaks of the flu have increased dramatically this year, according to…

Continue Reading

MondayJan 22, 2018 12:34 pm

ChineseInvestors.com, Inc. (CIIX) Sees Bright Future for Cryptocurrencies in China

Warren Wang, CEO of CIIX, says trading is active for cryptocurrencies in China on over-the-counter exchanges CIIX doubles down on its commitment to bitcoin and other cryptocurrencies, spinning off two other corporate divisions to spend more time on building its new cryptocurrency division The company’s goal is to gain revenue, profitability and value for its shareholders ChineseInvestors.com, Inc. (OTCQB: CIIX) sees a bright future for cryptocurrencies in China due to interest among Chinese investors in making cryptocurrencies part of their portfolios of assets (http://cnw.fm/kCt9V). Warren Wang, CEO of CIIX, said in a news release that the emerging middle class in…

Continue Reading

FridayJan 19, 2018 12:27 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Combining Nature and Science to Make Life Better

Company utilizing novel Caribbean blue scorpion venom therapy for immune system boost PreveCeutical seeks new ways to treat cancers, metabolic disorders, pain, infectious diseases and cardiovascular disease Partnership with University of Queensland researchers advances scientific scope of projects In the modern health care industry, disease prevention has taken a commanding role as screenings and regularly scheduled physician visits aim to minimize costs that could otherwise spiral out of control once a chronic condition is established. However, the Centers for Disease Control and Prevention report an ongoing concern that Americans are using preventive services at about half the recommended rate (http://cnw.fm/OIa4V).…

Continue Reading

FridayJan 19, 2018 11:26 am

Proposed Merger Expands Skinvisible, Inc. (SKVI) Horizons into Multi-Billion Dollar Pain Market

Company has developed and licensed novel drug delivery systems and products for over 15 years With 14 patents, Skinvisible has proven efficacy and global reach Proposed merger may transform non-opioid pain market At the cutting edge of innovative drug delivery technology since 1999, Skinvisible, Inc. (OTCQB: SKVI), in a recently announced Letter of Intent of a proposed merger with Quoin Pharmaceuticals, is now expanding its horizons into the global pain management therapeutics market. The pain management therapeutics market is projected to expand at a 3.7 percent CAGR and exceed $83 billion in the United States by 2024 (http://cnw.fm/pEyK9). Skinvisible, through…

Continue Reading

WednesdayJan 17, 2018 3:04 pm

Earth Science Tech, Inc. (ETST) Caps a Year of Achievement by Doubling Revenues

Portfolio of hemp-derived CBD products Opening of new production facilities New subsidiaries, acquisitions and joint ventures Earth Science Tech, Inc. (OTC: ETST) is celebrating another year of accomplishment. In 2017, the company churned out a series of advancements that included the launch of new subsidiaries and products and an acquisition, along with entry into marketing, manufacturing and distribution agreements. It also commenced pre-launch human trials of a new product designed to join the fight against opioid addiction. As a result, 2017 revenues were almost twice as much as in 2016. Now, even though the stock is trading at around $1.00,…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722